Literature DB >> 21716934

Genetic and epigenetic factors: Role in male infertility.

M B Shamsi1, K Kumar, R Dada.   

Abstract

Genetic factors contribute upto 15%-30% cases of male infertility. Formation of spermatozoa occurs in a sequential manner with mitotic, meiotic, and postmeiotic differentiation phases each of which is controlled by an intricate genetic program. Genes control a variety of physiologic processes, such as hypothalamus-pituitary-gonadal axis, germ cell development, and differentiation. In the era of assisted reproduction technology, it is important to understand the genetic basis of infertility to provide maximum adapted therapeutics and counseling to the couple.

Entities:  

Keywords:  Azoospermia; DNA damage; Y chromosome; cytogenetic; epigenetics; infertility; mRNA; mtDNA; oligozoospermia

Year:  2011        PMID: 21716934      PMCID: PMC3114572          DOI: 10.4103/0970-1591.78436

Source DB:  PubMed          Journal:  Indian J Urol        ISSN: 0970-1591


INTRODUCTION

There is increasing recognition of the contribution of genetic abnormalities to the causation of male infertility. The genetic factors involved in male infertility may be chromosomal or monogenic disorders, mitochondrial DNA (mtDNA) mutations, Y chromosome deletions, multifactorial disorders, imprinting disorders, or endocrine disorders of genetic origin. About 10% genes in the genome are related to spermatogenesis. Genetic abnormalities account for 15%–30% cases of male infertility[1] and may lead to irreversible partial or complete spermatogenic arrest. With the increased use of assisted reproduction technology (ART), our understanding of genetic basis of male infertility has large implications not only for understanding the cause of infertility but also in determining the prognosis and management of such couples.

CHROMOSOMAL ABNORMALITIES ASSOCIATED WITH INFERTILITY

Chromosomal abnormalities include both numerical and structural chromosomal aberrations, which are large enough (>4–5 Mb) to be discerned under the microscope. They account for 5%–10% cases of oligozoospermia, to 15%–25% cases with nonobstructive azoospermia.[1-3] In azoospermia, sex chromosome abnormalities are predominant. However, autosomal structural chromosomal abnormalities are the chief genetic cause of oligozoospermia and may be balanced (no gain or loss of genetic material) or unbalanced.

NUMERICAL ABERRATIONS

Numerical chromosome errors are a frequent cause of male infertility. The incidence is inversely proportional to the number of sperm in ejaculate.

47, XXY

Klinefelter syndrome [KFS] is the most common numerical chromosomal abnormality and is the most common cause of azoospermia. It is found in 11% cases with azoospermia. Men with 47,XXY [Figure 1] chromosomal complement are azoospermic due to seminiferous tubule dysgenesis, whereas mosaic cases with normal 46,XY cell line may be oligozoospermic. Identification of normal cell line is of critical importance as it indicates the presence of isolated foci of spermatogenesis, and thus is a good prognostic factor for ART. Studies on sperm chromosome from Klinefelter men have shown that the extra chromosome is eliminated during spermatogenesis.[4] Although majority of offspring from such men have normal chromosomal complement, the risk of chromosomally abnormal fetus is also high.[5] Frequency of aneuploidy for the sex chromosomes varies from 1.5%[6] to 7%[7] in sperm from Klinefelter mosaics, and 2%[8] to 45%[9] in the sperm of men who appear to have a nonmosaic 47,XXY karyotype.
Figure 1

G-banded karyotype showing 47,XXY chromosomal complement (Klinefelter syndrome)

G-banded karyotype showing 47,XXY chromosomal complement (Klinefelter syndrome)

46,XX male

This disorder affects 1 in 20,000 men. During paternal meiosis, aberrant translocation of Y material, including sex determining region (SRY) to the X chromosome leads to the 46,XX male chromosomal complement. Presence of SRY gene results in testicular differentiation but absence of spermatogenesis due to absence of long arm of Y chromosome.[10] Such men have normal sexual development with normal external genitilia but increased incidence of hypospadias and cryptorchidism.

STRUCTURAL ABERRATIONS

Translocations

Robertsonian translocations

Robertsonian translocations (RT) are found in 1 in 1000 individuals[11] and are the most common structural rearrangements in infertile men.[12] RT result in the fusion of the long arm of 2 acrocentric (Group D chromosomes: 13, 14, 15 and Group G chromosomes: 21, 22, and Y) chromosomes [Figure 2]. The fused short arms are mostly lost, and hence the carrier has a chromosomal constitution with 45 chromosomes. When the chromosomes pair during meiosis, they do so as a trivalent, and the resulting gametes can be chromosomally normal or aneuploid with an extra or missing long arm of chromosome.
Figure 2

(a) Schematic illustration of Robertsonian translocation; (b) G-banded karyotype showing 45,XY t (13;14) chromosomal complement

(a) Schematic illustration of Robertsonian translocation; (b) G-banded karyotype showing 45,XY t (13;14) chromosomal complement

Reciprocal translocations

Reciprocal translocations occur when there is exchange of genetic material between nonhomologous chromosomes. It affects 1.17% of infertile men.[13] During meiosis, 4 chromosomes pair as quadravalents and their segregation results in a higher frequency of unbalanced chromosomes as compared with carriers of RT. Risk of meiotic imbalance is primarily determined by the characteristics of the chromosomes involved, and the breakpoint positions. Many of these imbalances leads to fetal mortality and the average frequency of paternally derived translocation imbalance at prenatal diagnosis is 12%.[14] The frequency of chromosome abnormality is high, so these couples should undergo preimplantation genetic diagnosis (PGD) to implant only chromosomally normal or balanced embryos.

Inversions

These balanced structural rearrangements are found in 10%–15%[15] of prenatal diagnosis and 0.1% of infertile men.[13] Inversion occurs when 2 chromosome breaks occur on the same chromosome and join after 180° rotation. Inversion may be

Paracentric inversions

Paracentric inversions occur when both breakpoints are on one chromosome arm and do not involve the centromere.

Pericentric inversions

Pericentric inversions occur when the chromosome breaks include the centromere and the short and long arm of the chromosome. The inversions that produce recombinant chromosomes are, in general, large inversions encompassing more than half of the chromosome length.

Germline mosaics

Germline mosaics are men with a normal somatic karyotype but an abnormal cell line in their germ cells. They are discovered only on a testicular biopsy. Studies have discovered that 1%–17% of infertile men have germline mosaicism.[1617] The increased frequency of chromosomal abnormalities in intracytoplasmic sperm injection pregnancies and newborns reflects the increased frequency observed in the sperm of infertile men. Furthermore, studies have indicated that these chromosomal abnormalities are of paternal origin,[18] highlighting the fact that chromosomally abnormal sperm in such patients may lead to chromosomally abnormal offspring. It has also been suggested that abnormalities of the centrosome may exist in surgically retrieved sperm, a problem that may lead to increased mitotic nondisjunction and mosaicism in resulting embryos.[19]

GENES ASSOCIATED WITH INFERTILITY

Y chromosome genes

Y chromosome [Figure 3] is one of the smallest human chromosomes (60 Mb) and is highly polymorphic in length. It is male specific and the only haploid component of the human genome. Till now 156 transcription units, 78 protein coding genes, and 27 distinct proteins (9 on Yp and 18 on Yq) encoded by the Y chromosome have been identified.
Figure 3

Schematic representation showing human Y chromosome showing pseudoautosomal (PAR I and PAR II) and nonrecombining regions (MSY)

Schematic representation showing human Y chromosome showing pseudoautosomal (PAR I and PAR II) and nonrecombining regions (MSY) The Y chromosome is divided into 7 deletions intervals. The region critical for spermatogenesis is on interval 5 and 6. The length of euchromatic DNA sequences on the Y is about 23 Mb, including 8 Mb on the short arm and 14.5 Mb on the long arm. There are 3 classes of euchromatic sequences those transposed from the X chromosome during the process of the evolution of the Y (X-transposed), those similar to sequence information from the X chromosome (X-degenerate), and those repeated units across the proximal short arm of the Yp and across most of the Yq (amplicons). Within the X transposed segments, only 2 protein-encoding genes have been identified (TGIF2LY and PCDH11Y). The X-degenerate regions, with a combined length of 8.5 Mb, are dotted with single-copy genes or pseudogenes that are mostly expressed ubiquitously (ie, expressed in multiple organs in the body and not confined to a specific tissue). The sex-determining gene (SRY) is located in this region. The SRY gene expresses a transcription factor that switches on the genes for male sexual differentiation.[20] The genes in the AZFa (DBY and USP9Y) are located in the X-degenerate region. The most complex regions of the Y chromosome are the unique ampliconic regions in the euchromatin that are 10.5 Mb in length.[2021] Amplicons are families of units composed of nucleotide sequences that are similar to each other. They are located in 7 segments that are scattered across the euchromatin on Yp and Yq. The amplicons harbor the highest density of the Y chromosome genes that are exclusively expressed in the testes and enhance sexual fitness. Genes related to the AZFb and AZFc are located in the ampliconic regions. The array of the amplicons forms 8 palindromes (P1–P8).[20] A palindrome is a DNA sequence containing different amplicons, which has a twin along the chromosome that read the same in a reverse direction. Most of the recognized genes that are deleted in infertile men are located in the palindromic regions of the Yq.

Microdeletion of the Y chromosome

Microdeletions on the long arm of the Y chromosome (Yq) is one of the most significant pathogenic defects associated with male infertility. Tiepolo and Zuffardi in 1976, hypothesized a correlation between Y chromosome deletions and male infertility.[22] Yq microdeletions are found in 13% azoospermic men, 1%-7% severely oligozoospermic men (sperm count less than 0.5 million/mL). These deletions are clustered in interval 5 and 6 of the Y chromosome. It was defined as Azoospermia Factor (AZF) as the most severe phenotype associated with its deletion was azoospermia. The AZF region is further subdivided into 3 nonoverlapping regions termed as AZFa, AZFb, and AZFc. Six genes located in the AZF regions are expressed exclusively in the testes and are therefore known as “AZF candidate genes.”

The AZFa region

The AZFa spans around 400-600 kb of DNA and is located in the proximal portion of deletion interval 5. AZFa region harbors 2 protein encoding genes, namely, USP9Y and DBY (recently termed DDX3Y). Deletions of AZFa loci is characterized by Sertoli-cell-only syndrome, type I.[23]

The AZFb region

The AZFb spans around 1–3 Mb of DNA and is located on the distal portion of deletion interval 5 to the proximal end of deletion interval 6 (subinterval 5O–6B). Protein-encoding genes in AZFb region are EIF1AY, RPS4Y2, and SMCY that are located in X-degenerate euchromatin, and HSFY, XKRY, PRY, and RBMY that are in the ampliconic region.[23] The RBMY gene family encodes testis-specific RNA-binding proteins that are involved in mRNA processing, transport, and splicing. These are exclusively expressed in the germ cells and are 6 copies of this gene family in the AZFb region. AZFb gene is expressed in primary spermatocytes and thus its deletion leads to the arrest of meiosis and manifests as maturation arrest with the accumulation of primary spermatocytes.

The AZFc region

AZFc spans 3.5 Mb of euchromatin and is located at the distal part of deletion interval 6 (subinterval 6C-6E) on the Y chromosome.[22] Deletions of the AZFc region are most common in men with idiopathic oligozoospermia or azoospermia. In a study in our laboratory we found that 14% of the cases harbored AZFc deletion.[2] The AZFc region contains 8 gene families that are involved in spermatogenesis—BPY2, CDY, DAZ, CSPG4LY, GOLGAZLY, TTY3.1, TTY4.1, and TTY7. There are 4 copies of DAZ and it also has an autosomal homolog DAZL on 3p24. The first recognized gene in the AZFc was Deletion in Azoospermia factor (DAZ). This gene encodes RNA-binding proteins that are exclusively expressed in the germ cells.[20] Deletion of each member of DAZ may have different effects. Deletions in DAZ2, DAZ3, and DAZ4 copies are found in both fertile and infertile men and are described as familial variants inherited from father to son. However, DAZ1/ DAZ2 deletions are reported to be restricted only to infertile men. Deletions of AZFc regions are associated with a variable phenotype ranging from hypospermatogenesis to maturation arrest. Cases with AZFc deletions show a progressive deterioration in spermatogenesis and cases develop azoospermia over a period of time.[24]

gr/gr deletions

A number of infertile men harbor partial deletions in AZFb and AZFc loci. Considering the Y chromosome structure and the complexity of the deletion mechanism involved, it is possible that few other deletions also supplement the effect of partial AZFb and AZFc deletions. Frequency and pathologic significance of these partial deletions is still not known. de Llanos et al. reported a partial 1.6 Mb deletion on Y chromosome, termed as “gr/gr” deletion specifically in infertile men with varying degrees of spermatogenic failure.[25] The gr/gr deletion removes part of the AZFc region, including 2 copies of DAZ, 1 copy of CDY1, and a few transcription units. Since father-to-son transmission is observed, the gr/gr deletion probably results in subfertility rather than infertility. Another deletion termed as b2/b3 or u3-gr/gr or g1/g3, which removes a similar quantity of AZFc genes, has also been identified.[26]

CLINICAL IMPLICATIONS OF Y CHROMOSOME AZF DELETION

AZF deletions are specific for spermatogenic failure. The deletion of AZFa or AZFb loci and large deletions encompassing 2 or more loci lead to azoospermia and carry poor prognosis if such couples opt for ART. Cases with AZFc deletions have a variable phenotype and chances of sperm retrieval are high; however, such cases show progressive decline in sperm count over time and progress from oligozoospermia to azoospermia. [24] Such men are good candidates for ART but chances of iatrogenic transmission of Yq microdeletion to offspring must be explained to the couple.

AUTOSOMAL GENE MUTATIONS IN INFERTILITY

The complex interaction of gene products on both the sex chromosomes and the autosomes are essential for the fertility of an individual. Several autosomal genes, such as acrosin gene, BAX, BCL16, c-kit, ATM, HSP70.2, RAD6B, MDHC7, CREM, and DNA11 and 12, play an important role in germ cell development and spermiogenesis. Mutations of CFTR gene on chromosome 7 leads to obstructive azoospermia and is found in 60%–90% of patients with congenital bilateral absence of vas deferens (CBAVD). F508 del is the most common CFTR mutation found in 60%–70% of CBAVD patients. If both the partners have CFTR mutation, PGD should be done to avoid cystic fibrosis in the offspring.[27] Gene located on the chromosome 2 encodes for receptor of the follicle stimulating hormone and is another autosomal gene essential for fertility. Although there is no sufficient data correlating FSHR gene mutations and infertility in men, polymorphism of the FSHR gene affects the FSH receptivity in women. A few studies have correlated the FSHR gene mutations and abnormal spermatogenesis.[28] The methylenetetrahydrofolate reductase (MTHFR) plays a critical role in folate metabolism, and is essential for DNA methylation and spermatogenesis. The gene for MTHFR is located on chromosome 1 and any mutation in the MTHFR may disrupt the methylation of the nucleotides in the germ cells, a very sensitive regulatory step for the accurate transmission of genetic information to the offspring. The valine to alanine substitution due to C667T polymorphism in this gene reduces the activity of the enzyme. This reduced activity may lead to dysregulation of folic acid metabolism, ultimately manifesting as inaccurate methylation of nucleotides and subsequently impairing spermatogenesis.[29] Steroid 5-alpha reductase converts testosterone into dihydrotestosterone (DHT); a more active metabolite. DHT is required for spermatozoa maturation in the epididymis.[30] SRD5A1 and SRD5A2 are the 2 isozymes providing 5-alpha reductase activity.[31] SRD5A1 is expressed mainly in skin, whereas SRD5A2 in seminal vesicles.[32] Mutations in SRD5A2 gene located on chromosome 2, cause deficient virilization and pseudohermaphroditism.[33] Missense mutations in SRD5A2 gene affects the 5-alpha reductase activity. A valine-to-leucine and an alanine-to-threonine substitution at codon 89 and 49, respectively, has a higher frequency as compared with other amino acids, altering sequence variations.[34] Inguinoscrotal descent is controlled by several genes, namely, INSL3, LGR8, HOXA10, HOXA11, and ARID5B. Approximately 5% of cryptorchoid men have mutations in these genes.[35]

PROTAMINE AND TRANSITIONAL PROTEIN GENES

Gradual replacement of histones by transitional proteins (TP) followed by protamines (PRM) play a crucial role in sperm nuclear condensation. Equal proportions of PRM1 and PRM2 are present in spermatozoa of normal men, whereas the PRM1/PRM2 ratio is altered in infertile men.[3637] These altered levels could be either due to the pathogenic mutation in PRM/TNP genes or aberrant posttranslation modification of mRNAs. Thus abnormal condensation of sperm nucleus may lead to increased sperm DNA fragmentation, resulting in decreased sperm function, thus affecting male fertility.

X-Linked genes

Although it is believed that Y chromosome plays a major role in fertility regulation, several genes located on X chromosome also regulate fertility. Listed below are a few genes and syndromes with infertility as one of the clinical features, which are associated with genes on the X chromosome. Androgen insensitivity syndrome (AIS/IMS) is typically characterized by evidence of feminization of the external genitalia at birth, abnormal secondary sexual development at puberty, and infertility in individuals with a 46,XY karyotype.[3839] AIS represents a spectrum of defects in androgen action and can be subdivided into 3 broad phenotypes: complete AIS, with typical female genitalia; partial AIS with predominantly female, predominantly male, or ambiguous genitalia; and mild AIS with typical male genitalia.[40-43] AIS is inherited in an X-linked recessive manner. Affected 46,XY individuals are almost always infertile. Carrier females have a 50% chance of transmitting the AR gene (Xq11-12) mutation in each pregnancy. The USP26 gene located on the long arm of X chromosome is expressed in the preliminary stages of spermatogenesis. It is involved in histone removal during protamination. Increased histone levels in sperm DNA after complete differentiation is associated with increased sperm DNA damage. TAF7L is an X-linked (Xq22.1) germ cell-specific paralog of TAF7, which is generally expressed as a component of TFIID. It is known from studies that TAF7L gene is expressed during spermatogenesis, from the stage of spermatogenesis till the stage of round spermatids.[4445] The gene for Kallmann syndrome (KS) (KAL1), a form of idiopathic hypogonadotropic hypogonadism, is on the short arm of X chromosome. Deletions of KAL1 were found in 30%-70% cases of KS. The gene for the X-linked form was mapped to Xp22.3, spans 200,000 bp genomic DNA. Many different mutations in this gene, variably termed as KAL-X, KALIG-1, or ADMLX, were described in individuals with KS.

SYNDROMES ASSOCIATED WITH MALE INFERTILITY

Important syndromic cases linked to male infertility are KFS, AIS/IMS, KS, Kartagener syndrome, metabolic syndrome, Persistent Mullerian duct syndrome, Aarskog–Scott syndrome, Kearns–Sayre syndrome, Polyglandular failure syndrome types I and II, Bardet–Biedl syndrome, Noonan syndrome, Prader–Willi syndrome, deafness–infertility syndrome,[46] and others, which are yet to be investigated. These syndromic features may provide an early clue to the physician for the better treatment of the patients. Kartagener syndrome is a form of primary ciliary dyskinesia, which includes bronchiectasis, sinusitis, and sperm immotility with situs inversus. Metabolic syndrome (MetS) represents a constellation of abnormalities, including dyslipidemia, hypertension, and impaired glucose metabolism, with insulin resistance as the hypothesized underlying pathogenic mechanism. Male factor infertility may represent one such perturbation in some male patients with MetS. MetS is an important medical and epidemiologic entity, as its deleterious effect on patients is firmly established. Male infertility may represent another aberration observed in some patients with MetS. Currently, there is sufficient evidence to suggest the MetS–male infertility paradigm.[47] Obesity/overweight may result in hypogonadism, increased scrotal temperatures, impaired spermatogenesis, decreased sperm concentration and motility, and increased sperm DNA damage. Similarly, non insulin dependent diabetes melitus (NIDDM)/insulin resistance may contribute to and compound this scenario. Dyslipidemia with increased oxidative stress in the testicular microenvironment and/or excurrent ductal system may further decrease fertility. Kearns–Sayre syndrome belongs to a group of multisystemic disorders caused by mutations in the mitochondrial genome. This syndrome most prominently involves the neuromuscular and endocrine system. Pathology of the reproductive system is reported in 20%–30% affected males. Abnormal findings include cryptorchidism, pubertal delay, subnormal testicular volume, and low gonadotropin levels.

EPIGENETICS AND INFERTILITY

Difference in cells despite having the same genome arises because of the differential pattern of gene expression. Differential gene expression is produced by variability in the DNA-associated protein and its modifications (methylation, demethylation, acetylation, and deacetylation). These modifications are responsible for variable gene expression and constitute an integral component of epigenetics. Epigenetics has critical role in sperm development and function, fertilization, and postfertilization events. In the postmeiotic stage of spermatogenesis, transition proteins (TNP1 and TNP2) replace histones, which in turn are replaced with protamines. During the histone to transition protein substitution, core histone tail is hyperacetylated. The acetylation pattern determines the transcriptional status of a gene, hyperacetylation marking the gene with high transcriptional activity. A slight anomaly of this process can lead to sperm dysgenesis or aberration in chromatin packaging in spermatozoa, leading to infertility. Ratio between protamine1 (P1) and protamine2 (P2) acts as a marker of male fertility. In normal fertile men, this ratio (P1/P2) is 0.8 to 1.2.[48-50] Any deviation from this ratio is indicative of increased susceptibility to DNA damage and poor semen quality.[51-53] Phosphorylation and dephosphorylation of protamines also play a vital role in sperm function, for example, CamK4 phosphorylates protamine2 and it is observed that mutations in CamK4 lead to derangement in spermatogenesis, and therefore male infertility. Abnormalities in protamine packaging of DNA causes aberrant gene expression resulting in either hypertranscription or transcriptional arrest, leading to failure in spermatogenesis.[54] Studies suggest that spermatozoa convey a wide variety of epigenetic information to the oocyte, which has an important role in postfertilization events. DNA in sperm is not homogeneously packed. The peripheral portion of nuclear DNA (15%) is packaged with histones and the inner core of DNA is a highly compact crystalline structure bound to protamines.[55] Ooplasm plays an important role in demethylation of paternal DNA after fertilization. The nucleosomes derived from spermatozoa remain attached to paternal genome in zygote before the S-phase,[56] which gives a clue that these nucleosomes might be involved in epigenetic functions in postfertilization developmental events. Brother of regulator of imprinting sites (BORIS), an epigenetic factor specifically expressed in male gonads plays a crucial part in methylation levels in male germ cell differentiation.[57] BORIS along with other factors (CCCTC-binding factor and insulator protein) binds to specific DNA regions (during spermatogenesis) and prevent interaction between promoter and enhancer region, which as a consequence modulates spermatogenesis-specific gene expression, producing normal sperms. Thus BORIS plays a decisive role in spermatogenesis and male fertility.[58]

MITOCHONDRIAL DNA MUTATIONS AND INFERTILITY

mtDNA is circular DNA molecule that codes for 13 polypeptides of the oxidative phosphorylation pathway. Mitochondrial DNA is a naked molecule, lacks introns and histones and both strands are transcribed to synthesize a functional protein. mtDNA mutates at a rate 10–20 times higher than nuclear DNA due to asexual method of replication, a very basic repair mechanism, lack of protective histones, and increased proximity to the site of free radical generation. Mitochondria are located in sperm midpiece and each mitochondria has 1 mtDNA copy.[59-61] Spermatozoa exist in a state of oxygen paradox and have higher energy requirement to support their movement after ejaculation. Thus, random attacks on the naked mtDNA of sperms by reactive oxygen species (ROS) or free radicals causes oxidative damage or mutation to the mt genome, which leads to infertility.[6263] In infertile men, 3 large deletions occur in higher frequency as compared with fertile men. The 4977-bp, 7345-bp, and 7599-bp deletions in the sperm genome are detrimental to the sperm reproductive potential because these deletions span the ATPase 8 and 6, COII, ND3, ND4, ND5, ND6, and cytochrome b oxidase coding components of the oxidative phosphorylation (OXPHOS) pathway.[6465] A 15-bp deletion in the cytochrome c oxidase subunit (COX III) of complex IV is also reported to be associated with motility loss in sperms.[66] Two base pair deletions at 8195-8196 in the CO II gene and a A3243 G substitution is also reported in men with impaired sperm parameters.[6768] In an ongoing study in our laboratory, we found increased number of nonsynonymous nucleotide changes in sperm mtDNA of oligoasthenoteratozoospermic (OAT) men as compared with controls;[59] these men had increased ROS levels[62] and also increased nuclear DNA damage.[69] Although much remains to be learnt, a considerable progress has been made in the clinical delineation of genetic forms of male infertility and in the characterization of the responsible genes and their mutations or deletions. It is important to characterize if the genetic etiology is mt or nuclear as cases with mtDNA defects have good prognosis since there is no paternal transmission of mtDNA.

DNA DAMAGE AND INFERTILITY

The sperm chromatin is highly condensed, stable, and is one sixth the size of somatic cell nucleus. It is one transcriptionally inactive. During spermiogenesis, histones are replaced by TP, which subsequently are replaced by PRM,[7071] which have a high degree of disulfide bonds and make the sperm DNA crystalline. DNA damage manifests as DNA fragmentation and DNA denaturation. Sperm DNA integrity is defined as the absence of DNA nicks or single-/double-stranded breaks and chemical modifications of DNA. The nuclear DNA damage does not impair fertilization or cleavage as paternal genome is activated 72 h postfertilization. Sperm DNA damage results in poor blastocyst development, unequal cleavage, implantation failure, or early fetal loss. Although oocyte repair mechanism repair the damaged sperm DNA, increased DNA damage overwhelms oocyte repair capacity. Certain products of oxidative stress as etheno-nucleosides inhibit oocyte repair capacity by impairing nucleotide excision repair mechanism of oocyte. Higher degree of negative association between the degree of DNA damage with various indices of fertility as fertilization rate, embryo cleavage rate, implantation rate, pregnancy, and live birth rate have been observed.[72] The spontaneous abortion rate is 1.7-fold higher when more than 30% of sperms contain fragmented DNA. The chances of live birth and conception decreases drastically when DNA fragmentation index is >30.[73] Infertile men may have sperm with normal sperm parameters, but the germ cells may harbor DNA damage, which cannot be predicted by routine semen analysis. Using these sperm with damaged DNA for ART may lead to increased genetic and epigenetic defects in offspring, childhood malignancies, and increased risk of major and minor congenital malformation.[74] Sperm DNA damage is also one of the major underlying causes of recurrent spontaneous abortions.[75] Several factors lead to DNA damage, such as oxidative stress,[69757677] defective chromatin packing, ultracentrifugation, increased histone to protamine ratio, exposure to pollutants, xenobiotics, high temperature and cell phone radiation. The threshold clinical values for the DNA damage beyond which conception is not possible is not optimized yet due to the logistic constrains of the numerous techniques considered. The values are just an approximation depending on the technique adopted. TUNEL, comet, sperm chromatin dispersion, and sperm chromatin structure assay are few of the common techniques. In a study done in our laboratory, we found that in infertile men 40% of the sperms had a very high degree of DNA damage as assessed by increased tail length comet assay.[697677] Compared with conventional semen analysis, the techniques for DNA damage assessment provide more clinically relevant information with regard to fertility potential of an individual, and these techniques have a very significant role to play in the era of ART where the process of natural selection is bypassed.

mRNA AND INFERTILITY

RNA profiling of fertile and infertile men has shown dynamic cellular variation, and thus has proved to be a biomarker for male infertility. Round spermatids contain numerous varieties of transcripts that are produced either throughout early spermatogenesis or during spermiogenesis from the haploid genome coding for sperm-specific proteins. The transcripts are stored in spermatid cytoplasm before the related proteins are expressed.[78] In midspermiogenesis, the chromatin remodeling leads to the transcriptional inactivation of the genome.[79] Thus the highly condensed sperm nucleus is transcriptionally inert and contains diverse RNA population, mRNA, antisense, and miRNAs that have been transcribed prior to inactivation.[80-83] The presence of transcripts in human spermatozoa has been established using reverse transcription polymerase chain reaction (PCR) and real-time PCR.[84] The functional significance of spermatozoa RNAs in male fertility was determined by the identification of their role in spermatogenesis, fertilization, and early embryo development. Ostermeier et al. reported that some of these RNAs are transmitted to the oocyte during fertilization.[85] In their later studies, they provided evidence for the presence of interfering RNAs (iRNAs) in spermatozoa.[86] Emery and Carrel,[87] in 2006, reported that altered mRNA profiles contribute to idiopathic male infertility and may affect in vitro fertilization outcome. Six candidate transcripts present only in human spermatozoa and not in oocytes have been identified, which indicates the transfer of RNAs from sperm to oocyte. These RNAs are clusterin, AKAP4 (A-kinase anchoring protein 4), protamine-2, HSBP1 (Heat shock-binding protein 1), FOXG1B (forkhead box G1B), and WNT5A (wingless-type MMTV integration site family). Clusterin is involved in sperm maturation, lipid transportation, stabilization of stress proteins, and it also influences the oocyte-penetration capacity of cauda epididymal sperm.[8889] The PRM-2 transcript is degraded in the 2-cell embryo stage.[90] AKAP4 regulates the motility and also plays an important role in cell signaling process.[91] FOXG1B and WNT5A are critical for early embryo patterning,[92] whereas WNT5A is also important for cellular differentiation.[93] Sperm mRNAs coding for protamines are a useful biomarker for predicting male infertility. Sperm haploinsufficiency for the prm1 and prm2 results in aberrant sperm chromatin condensation and the aberrant prm1/prm2 ratio play an important role in male infertility.[94] Small RNAs mediate transcriptional gene silencing by methylation[9596] ; also the miRNA's class of transcripts help in the establishment of imprints in early embryos.[85] RNA profiles of mature, ejaculated spermatozoa reflect spermatogenic gene expression.[9798] Gene expression studies by microarray on spermatozoal RNA have shown that mRNA profile of infertile men is distinct from the fertile controls.[99] In a study done by Platts[100] et al., 2007, reported that teratozoospermic men have a distinctive mRNA profile, which can be used in a predictive manner. Thus the differences in the spermatozoa transcriptomes between groups has potential diagnostic and therapeutic possibilities and could be helpful in determining the underlying etiology of male infertility.

CONCLUSION

Male fertility is regulated by a number of genes, which regulate spermatogenesis and are required for DNA recombination, repair, and replication. The maintenance of genomic integrity is of vital importance for germ cells. Using the advanced approaches of genomics and proteomics and applying the advanced gene expression techniques as microarray would help to interpret the causative mechanisms for infertility. This would not only minimize the risks associated with ART but will also provide an insight into the unexplored aspects of infertility. Thus not only understanding the role of fertility-related genes is needed but also a deeper insight into the functions of promoters, regulators, and micro-RNA is required. Although much has been explored to understand the interactive mechanisms associated with fertility, still there are lacunae in our knowledge that need to be filled, so that the treatment of infertility becomes better and a nonempirical approach can be adopted in idiopathic cases. It would also help the ART clinicians, in aiding their patients to produce healthy fertile offspring.
  95 in total

Review 1.  Homocysteine metabolism.

Authors:  J Selhub
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

2.  An unusual form of purifying selection in a sperm protein.

Authors:  A P Rooney; J Zhang; M Nei
Journal:  Mol Biol Evol       Date:  2000-02       Impact factor: 16.240

3.  Reproductive biology: delivering spermatozoan RNA to the oocyte.

Authors:  G Charles Ostermeier; David Miller; John D Huntriss; Michael P Diamond; Stephen A Krawetz
Journal:  Nature       Date:  2004-05-13       Impact factor: 49.962

4.  Spermatogenesis in Klinefelter syndrome.

Authors:  R Selice; A Di Mambro; A Garolla; V Ficarra; M Iafrate; A Ferlin; C Foresta
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

5.  200 infertile males: correlation of chromosome, histological, endocrine and clinical studies.

Authors:  W F Hendry; P E Polani; R C Pugh; I F Sommerville; D M Wallace
Journal:  Br J Urol       Date:  1975

6.  CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men.

Authors:  Ewa Rajpert-De Meyts; Henrik Leffers; Jørgen H Petersen; Anne Grethe Andersen; Elisabeth Carlsen; Niels Jørgensen; Niels E Skakkebaek
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

7.  Complete selective absence of protamine P2 in humans.

Authors:  L de Yebra; J L Ballescà; J A Vanrell; L Bassas; R Oliva
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

Review 8.  Regulation of epididymal epithelial cell functions.

Authors:  B Robaire; R S Viger
Journal:  Biol Reprod       Date:  1995-02       Impact factor: 4.285

Review 9.  Cytogenetic determinants of male fertility.

Authors:  R H Martin
Journal:  Hum Reprod Update       Date:  2008-06-04       Impact factor: 15.610

10.  Mitochondrial DNA Mutations in etiopathogenesis of male infertility.

Authors:  Monis Bilal Shamsi; Rakesh Kumar; Audesh Bhatt; R N K Bamezai; Rajeev Kumar; Narmada P Gupta; T K Das; Rima Dada
Journal:  Indian J Urol       Date:  2008-04
View more
  15 in total

1.  The Nsun7 (A11337)-deletion mutation, causes reduction of its protein rate and associated with sperm motility defect in infertile men.

Authors:  Nahid Khosronezhad; Abasalt Hosseinzadeh Colagar; Seyed Mohsen Mortazavi
Journal:  J Assist Reprod Genet       Date:  2015-02-22       Impact factor: 3.412

2.  [CMTM2 is involved in spermiogenesis in mice].

Authors:  X W Zhang; H Q Yin; Q Li; Y P Zhao; K Brandes; W J Bai; T Xu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-18

3.  Lack of association between genetic polymorphisms in three folate-related enzyme genes and male infertility in the Chinese population.

Authors:  Wuhua Ni; Haiyan Li; Aihua Wu; Peili Zhang; Haiyan Yang; Xu Yang; Xuefeng Huang; Lei Jiang
Journal:  J Assist Reprod Genet       Date:  2015-01-13       Impact factor: 3.412

4.  A lack of a definite correlation between male sub-fertility and single nucleotide polymorphisms in sperm mitochondrial genes MT-CO3, MT-ATP6 and MT-ATP8.

Authors:  Mayyas Saleh Jaweesh; Mohamad Eid Hammadeh; Fatina W Dahadhah; Mohammad A Al Smadi; Mazhar Salim Al Zoubi; Manal Issam Abu Alarjah; Houda Amor
Journal:  Mol Biol Rep       Date:  2022-09-06       Impact factor: 2.742

5.  Ubiquitin-specific protease (USP26) gene alterations associated with male infertility and recurrent pregnancy loss (RPL) in Iranian infertile patients.

Authors:  U Asadpor; M Totonchi; M Sabbaghian; H Hoseinifar; M R Akhound; Sh Zari Moradi; K Haratian; M A Sadighi Gilani; H Gourabi; A Mohseni Meybodi
Journal:  J Assist Reprod Genet       Date:  2013-06-19       Impact factor: 3.412

6.  TDRP deficiency contributes to low sperm motility and is a potential risk factor for male infertility.

Authors:  Shanhua Mao; Fei Wu; Xinyi Cao; Min He; Naijia Liu; Huihui Wu; Zhihong Yang; Qiang Ding; Xuanchun Wang
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

7.  Study of single nucleotide polymorphism (rs28368082) in SPO11 gene and its association with male infertility.

Authors:  Esmat Ghalkhani; Masoud Sheidai; Hamid Gourabi; Zahra Noormohammadi; Narjes Bakhtari; Ali Mohammad Malekasgar
Journal:  J Assist Reprod Genet       Date:  2014-07-09       Impact factor: 3.412

8.  Genotyping of the EIF1AY Gene in Iranian Patients with Non-Obstructive Azoospermia.

Authors:  Elham Yarahmadi; Parnaz Borjian Boroujeni; Mehdi Totonchi; Hamid Gourabi
Journal:  Curr Urol       Date:  2019-09-10

Review 9.  Cell-free DNA discoveries in human reproductive medicine: providing a new tool for biomarker and genetic assays in ART.

Authors:  Maryam Qasemi; Reza Mahdian; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2021-01-09       Impact factor: 3.412

Review 10.  Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action.

Authors:  Giacomo Tirabassi; Angelo Cignarelli; Sebastio Perrini; Nicola Delli Muti; Giorgio Furlani; Mariagrazia Gallo; Francesco Pallotti; Donatella Paoli; Francesco Giorgino; Francesco Lombardo; Loredana Gandini; Andrea Lenzi; Giancarlo Balercia
Journal:  Int J Endocrinol       Date:  2015-09-02       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.